4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011553
Chief Business Development Off sold 16,250 shares at an average $64.64 ($1,050,381)
- Chief Business Development Off acquired 16,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Business Development Off
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-16 | Exercise or conversion : show line 1 in the form | +16,250 | $31.71 | $515,288 | 16,250 | D |
| 2021-02-16 | Sale : show line 2 in the form | −5,022 | $63.42 | $318,495 | 11,228 | D |
| 2021-02-16 | Sale : show line 3 in the form | −1,700 | $64.59 | $109,803 | 9,528 | D |
| 2021-02-16 | Sale : show line 4 in the form | −9,528 | $65.29 | $622,083 | 0 | D |
| Open-market sales · 16,250 sh · avg $64.64 · $1,050,381 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-16 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −16,250 | 48,750 | D |
Loading xslF345X03/doc4.xml…